Hamza Hassan

11PUBLICATIONS
72CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Aug 04, 2025
Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma.

Joshua Rivera, Qi Yan, Saeed Daneshmandi

|Apr 11, 2025
The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.

Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan

|Feb 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis.

Eli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala

|Aug 29, 2024
Long-term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system.

Eli Muchtar, Morie A Gertz, Raphael Mwangi

Pageof 2

Frequent Collaborators

4 joint publications

Morie Gertz

3 joint publications

Hans C Lee

3 joint publications

Vaishali Sanchorawala

3 joint publications

Eli Muchtar